361 related articles for article (PubMed ID: 22784431)
1. Indole-3-carbinol blocks platelet-derived growth factor-stimulated vascular smooth muscle cell function and reduces neointima formation in vivo.
Guan H; Chen C; Zhu L; Cui C; Guo Y; Fu M; Wang L; Tang Q
J Nutr Biochem; 2013 Jan; 24(1):62-9. PubMed ID: 22784431
[TBL] [Abstract][Full Text] [Related]
2. 3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.
Guan H; Zhu L; Fu M; Yang D; Tian S; Guo Y; Cui C; Wang L; Jiang H
PLoS One; 2012; 7(4):e34957. PubMed ID: 22506059
[TBL] [Abstract][Full Text] [Related]
3. Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation.
Guan H; Gao L; Zhu L; Yan L; Fu M; Chen C; Dong X; Wang L; Huang K; Jiang H
J Cell Biochem; 2012 Apr; 113(4):1198-207. PubMed ID: 22095643
[TBL] [Abstract][Full Text] [Related]
4. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury.
Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B
Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423
[TBL] [Abstract][Full Text] [Related]
5. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
[TBL] [Abstract][Full Text] [Related]
6. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306
[TBL] [Abstract][Full Text] [Related]
7. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
[TBL] [Abstract][Full Text] [Related]
8. Salidroside blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet‑derived growth factor‑BB.
Chen C; Tang Y; Deng W; Huang C; Wu T
Mol Med Rep; 2014 Aug; 10(2):917-22. PubMed ID: 24840151
[TBL] [Abstract][Full Text] [Related]
9. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
[TBL] [Abstract][Full Text] [Related]
10. Phloretin Inhibits Platelet-derived Growth Factor-BB-induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury.
Wang D; Wang Q; Yan G; Qiao Y; Tang C
J Cardiovasc Pharmacol; 2015 May; 65(5):444-55. PubMed ID: 25945863
[TBL] [Abstract][Full Text] [Related]
11. Piperine inhibits platelet-derived growth factor-BB-induced proliferation and migration in vascular smooth muscle cells.
Lee KP; Lee K; Park WH; Kim H; Hong H
J Med Food; 2015 Feb; 18(2):208-15. PubMed ID: 25384161
[TBL] [Abstract][Full Text] [Related]
12. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Calcium Inhibits PDGF-ββ-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFRβ-PI3K-Akt Signaling Cascade.
Chen S; Dong S; Li Z; Guo X; Zhang N; Yu B; Sun Y
Cell Physiol Biochem; 2017; 44(1):215-228. PubMed ID: 29131001
[TBL] [Abstract][Full Text] [Related]
14. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
[TBL] [Abstract][Full Text] [Related]
15. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
16. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-kappaB activation in vascular smooth muscle cells.
Karki R; Ho OM; Kim DW
Biochim Biophys Acta; 2013 Mar; 1830(3):2619-28. PubMed ID: 23274740
[TBL] [Abstract][Full Text] [Related]
17. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.
Seo J; Lee HS; Ryoo S; Seo JH; Min BS; Lee JH
Eur J Pharmacol; 2011 Dec; 673(1-3):56-64. PubMed ID: 22040922
[TBL] [Abstract][Full Text] [Related]
18. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
[TBL] [Abstract][Full Text] [Related]
19. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
20. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]